Plunkett Research Online: MiMedx Group Inc

MIMEDX GROUP INC (MDXG:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key prod.....



MiMedx Group Inc
Ticker: MDXG
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 770-651-9100
Fax:
Address: 1775 West Oak Commons Court, NE
Marietta, GA 30062 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Implants, Surgical, Manufacturing
Contacts Description
Joseph CapperCEO/Director
Douglas RiceCFO
See More

Auditor: Deloitte & Touche LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
AmnioFix
EpiFix
EpiBurn
AmnioFill
AmnioCord
EpiCord
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: